Stock comparison

BRK.BvsJNJ

Berkshire Hathaway Inc vs Johnson & Johnson. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BRK.B

Berkshire Hathaway Inc

$474.58

-3.23%

Financial Services$1.03TNYSE

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE

60-day price, rebased to 100

BRK.B -1.84% · JNJ +7.18%

Round-by-round

BRK.B 3·JNJ 2· 1 tie

EdgeBRK.B

Valuation upside

+118373.60% vs -49.50% to DCF fair value

EdgeJNJ

Balance-sheet strength

Altman Z 2.64 vs 5.48

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

EdgeBRK.B

Growth + margins

Rule-of-40 2.70 vs -5.70

EdgeJNJ

60-day momentum

-1.84% vs +7.18% price return

EdgeBRK.B

Market-cap liquidity

$1.03T vs $585.7B

Verdict

Across 6 categories, BRK.B takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on BRK.B or JNJ

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.